Igovomab

N/A

Report date: 2025/11/24 11:49:38

Base Information

Drug NameIgovomab

Drug Alias NameOC125 chelator DTPA伊戈伏单抗诊断试剂 - CIS Bio InternationalOC 125 F(ab')2-DTPA 111InIndimacis 125

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive therapeutic agent +[5]

Mechanisms of ActionImmunomodulatorsRadionuclide imaging enhancers

TargetsMucin-16

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsOvarian Neoplasms

Approved Indications in ChinaN/A

Original Approved Country/TerritoryEU

Original Approved Date1996/10/04

Country/TerritoryEU

CombinationsNo

Global Highest StatusWithdrawn

Highest Status in ChinaN/A

Originator CompaniesCis Bio International Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCis Bio International Sa

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeV09IB03